Jeffrey Scott Sherman - Chief Financial Officer at NEOGENOMICS INC

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Jeffrey Scott Sherman in NEOGENOMICS INC

Buys

Open market
Shares
+20,000
Avg price
$5.62
Total value
+$112,322

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+20,000
Share %
100%
Total value
+$112,322

Reported holdings for Jeffrey Scott Sherman in NEOGENOMICS INC

Form 4 holding Chief Financial Officer

NEOGENOMICS INC

Security class
Stock Option (Right to Buy)
Shares / value
214,900
Estimated value
$2,664,760
Report date
21 Feb 2026
Price
$12.40
Ownership
Direct
Underlying class
Common Stock
Underlying amount
214,900
Form 4 holding Chief Financial Officer

NEOGENOMICS INC

Security class
Performance Stock Unit
Shares / value
46,606
Estimated value
$577,914
Report date
21 Feb 2026
Price
$12.40
Ownership
Direct
Underlying class
Common Stock
Underlying amount
46,606
Form 4 holding Chief Financial Officer

NEOGENOMICS INC

Security class
Restricted Stock Unit
Shares / value
15,536
Estimated value
$192,646
Report date
23 Feb 2026
Price
$12.40
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,536

Transaction history for Jeffrey Scott Sherman in NEOGENOMICS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .